Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Sumitomo Pharma
>>
Phase 3
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
3
6
9
12
15
18
21
24
27
30
napabucasin
(BBI608) / Sumitomo Pharma
ulotaront
(SEP-363856) / Otsuka, PsychoGenics
Calsed
(amrubicin) / Sumitomo Pharma, BMS
Vincerinone
(vatiquinone) / Sumitomo Pharma, PTC Therap
Xopenex HFA
(levalbuterol tartrate) / Sumitomo Pharma
dasotraline
(SEP-225289) / Sumitomo Pharma
Xenleta
(lefamulin oral) / Nabriva Therap, Sumitomo Pharma
adegramotide/nelatimotide
(DSP-7888) / Sumitomo Pharma
non-racemic amisulpride
(SEP-4199) / Sumitomo Pharma, Otsuka
Remitch OD
(nalfurafine hydrochloride orally disintegrating tablet) / Toray, Japan Tobacco, Sumitomo Pharma
Xenleta
(lefamulin IV) / Nabriva Therap, Sumitomo Pharma, Er-Kim Pharma
Lonasen tape
(blonanserin transdermal patch) / Nitto Denko, Sumitomo Pharma
ranirestat
(AS-3201) / Sumitomo Pharma, Eisai
Fulstan
(falecalcitriol) / Kissei, Sumitomo Pharma, Taisho
